{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:21:14Z","timestamp":1794320474329,"version":"4.9.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41371-020-0352-2","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T11:02:53Z","timestamp":1589799773000},"page":"682-691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Blood\u2013brain barrier dysfunction: the undervalued frontier of hypertension"],"prefix":"10.1038","volume":"34","author":[{"given":"Vasiliki","family":"Katsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Marketou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Maragkoudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8046-0602","authenticated-orcid":false,"given":"Matthaios","family":"Didagelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fragkiskos","family":"Parthenakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tousoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"352_CR1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.prp.2014.05.007","volume":"210","author":"MT Mohammadi","year":"2014","unstructured":"Mohammadi MT, Dehghani GA. Acute hypertension induces brain injury and blood\u2013brain barrier disruption through reduction of claudins mRNA expression in rat. Pathol Res Pr. 2014;210:985\u201389.","journal-title":"Pathol Res Pr"},{"key":"352_CR2","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1111\/j.1753-4887.2010.00352.x","volume":"6","author":"RN Kalaria","year":"2010","unstructured":"Kalaria RN. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev. 2010;6:S74\u2013S87.","journal-title":"Nutr Rev"},{"key":"352_CR3","first-page":"w13892","volume":"143","author":"A Keller","year":"2013","unstructured":"Keller A. Breaking and building the wall: the biology of the blood\u2013brain barrier in health and disease. Swiss Med Wkly. 2013;143:w13892.","journal-title":"Swiss Med Wkly"},{"key":"352_CR4","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood\u2013brain barrier. Nat Med. 2013;19:1584\u201396.","journal-title":"Nat Med"},{"key":"352_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2015.01.002","volume":"38","author":"Y Serlin","year":"2015","unstructured":"Serlin Y, Shelef I, Knyazer B, Friedman A. Anatomy and physiology of the blood\u2013brain barrier. Semin Cell Dev Biol. 2015;38:2\u20136.","journal-title":"Semin Cell Dev Biol"},{"key":"352_CR6","doi-asserted-by":"publisher","first-page":"R405","DOI":"10.1152\/ajpregu.00103.2010","volume":"299","author":"PM Smith","year":"2010","unstructured":"Smith PM, Ferguson AV. Circulating signals as critical regulators of autonomic state\u2013central roles for the subfornical organ. Am J Physiol Regul Integr Comp Physiol. 2010;299:R405\u201315.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"352_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.resp.2011.05.004","volume":"178","author":"H Waki","year":"2011","unstructured":"Waki H, Gouraud SS, Maeda M, Raizada MK, Paton JF. Contributions of vascular inflammation in the brainstem for neurogenic hypertension. Respir Physiol Neurobiol. 2011;178:422\u20138.","journal-title":"Respir Physiol Neurobiol"},{"key":"352_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brainres.2015.03.018","volume":"1623","author":"PT Ronaldson","year":"2015","unstructured":"Ronaldson PT, Davis TP. Targeting transporters: promoting blood\u2013brain barrier repair in response to oxidative stress injury. Brain Res. 2015;1623:39\u201352.","journal-title":"Brain Res"},{"key":"352_CR9","doi-asserted-by":"publisher","first-page":"H1598","DOI":"10.1152\/ajpheart.00490.2012","volume":"304","author":"PW Pires","year":"2013","unstructured":"Pires PW, Dams Ramos CM, Matin N, Dorrance AM. The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol. 2013;304:H1598\u2013H1614.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"352_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0006-8993(00)02954-1","volume":"885","author":"A Lippoldt","year":"2000","unstructured":"Lippoldt A, Kniesel U, Liebner S, Kalbacher H, Kirsch T, Wolburg H, et al. Structural alterations of tight junctions are associated with loss of polarity instroke-prone spontaneously hypertensive rat blood\u2013brain barrier endothelial cells. Brain Res. 2000;885:251\u201361.","journal-title":"Brain Res"},{"key":"352_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1023\/B:NERE.0000014828.32200.bd","volume":"29","author":"KH Tan","year":"2004","unstructured":"Tan KH, Harrington S, Purcell WM, Hurst RD. Peroxynitrite mediatesnitric oxide-induced blood\u2013brain barrier damage. Neurochem Res. 2004;29:579\u201387.","journal-title":"Neurochem Res."},{"key":"352_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0022-510X(95)00105-B","volume":"131","author":"DL Sparks","year":"1995","unstructured":"Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC 3rd. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci. 1995;131:162\u20139.","journal-title":"J Neurol Sci"},{"key":"352_CR13","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1152\/ajpheart.00589.2003","volume":"285","author":"KA Witt","year":"2003","unstructured":"Witt KA, Mark KS, Hom S, Davis TP. Effects of hypoxia-reoxygenation on rat blood\u2013brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol. 2003;285:2820\u201331.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"352_CR14","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.3390\/ijms20133223","volume":"20","author":"N Szarka","year":"2019","unstructured":"Szarka N, Toth L, Czigler A, Kellermayer Z, Ungvari Z, Amrein K, et al. Single mild traumatic brain injury induces persistent disruption of the blood\u2013brain barrier, neuroinflammation and cognitive decline in hypertensive rats. Int J Mol Sci. 2019;20:3223.","journal-title":"Int J Mol Sci"},{"key":"352_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1242\/jcs.02734","volume":"119","author":"SR Parathath","year":"2006","unstructured":"Parathath SR, Parathath S, Tsirka SE. Nitric oxide mediates neurodegeneration and breakdown of the blood\u2013brain barrier in tPA-dependent excitotoxic injury in mice. J Cell Sci. 2006;119:339\u201349.","journal-title":"J Cell Sci"},{"key":"352_CR16","doi-asserted-by":"publisher","first-page":"297512","DOI":"10.1155\/2013\/297512","volume":"2013","author":"AM Enciu","year":"2013","unstructured":"Enciu AM, Gherghiceanu M, Popescu BO. Triggers and effectors of oxidative stress at blood\u2013brain barrier level: relevance for brain ageing and neurodegeneration. Oxid Med Cell Longev. 2013;2013:297512.","journal-title":"Oxid Med Cell Longev"},{"key":"352_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01743","volume":"63","author":"VC Biancardi","year":"2014","unstructured":"Biancardi VC, Son SJ, Ahmadi S, Filosa JA, Stern JE. Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood\u2013brain barrier. Hypertension. 2014;63:572\u20139.","journal-title":"Hypertension"},{"key":"352_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","volume":"29","author":"MA Fleegal\u2010DeMotta","year":"2009","unstructured":"Fleegal\u2010DeMotta MA, Doghu S, Banks WA. Angiotensin II modulates BBB permeability via activation of the AT1 receptor in brain endothelial cells. J Cereb Blood Flow Metab. 2009;29:640\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"352_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1549-8719.2010.00060.x","volume":"17","author":"SA Vital","year":"2010","unstructured":"Vital SA, Terao S, Nagai M, Granger DN. Mechanisms underlying the cerebral microvascular responses to angiotensin II\u2010induced hypertension. Microcirculation. 2010;17:641\u20139.","journal-title":"Microcirculation"},{"key":"352_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuroscience.2013.04.023","volume":"245","author":"ST Yao","year":"2013","unstructured":"Yao ST, May CN. Intra\u2010carotid angiotensin II activates tyrosine hydroxylase\u2010expressing rostral ventrolateral medulla neurons following blood\u2013brain barrier disruption in rats. Neuroscience. 2013;245:148\u201356.","journal-title":"Neuroscience"},{"key":"352_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.neuroscience.2010.09.029","volume":"171","author":"M Zhang","year":"2010","unstructured":"Zhang M, Mao Y, Ramirez SH, Tuma RF, Chabrashvili T. Angiotensin II induced cerebral microvascular inflammation and increased blood\u2013brain barrier permeability via oxidative stress. Neuroscience. 2010;171:852\u20138.","journal-title":"Neuroscience"},{"key":"352_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.112.195511","volume":"60","author":"D Carnevale","year":"2012","unstructured":"Carnevale D, Mascio G, D\u2019Andrea I, Fardella V, Bell RD, Branchi I, et al. Hypertension induces brain \u03b2-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension. 2012;60:188\u201397.","journal-title":"Hypertension"},{"key":"352_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","volume":"139","author":"S Oparil","year":"2003","unstructured":"Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003;139:761\u201376.","journal-title":"Ann Intern Med"},{"key":"352_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","volume":"97","author":"B Rodriguez-Iturbe","year":"2017","unstructured":"Rodriguez-Iturbe B, Pons H, Johnson RJ. Role of the immune system in hypertension. Physiol Rev. 2017;97:1127\u201364.","journal-title":"Physiol Rev"},{"key":"352_CR25","doi-asserted-by":"publisher","first-page":"164653","DOI":"10.1155\/2013\/164653","volume":"2013","author":"I Gonz\u00e1lez-Marrero","year":"2013","unstructured":"Gonz\u00e1lez-Marrero I, Casta\u00f1eyra-Ruiz L, Gonz\u00e1lez-Toledo JM, Casta\u00f1eyra-Ruiz A, de Paz-Carmona H, Castro R, et al. High blood pressure effects on the blood to cerebrospinal fluid barrier and cerebrospinal fluid protein composition: a two-dimensional electrophoresis study in spontaneously hypertensive rats. Int J Hypertens. 2013;2013:164653.","journal-title":"Int J Hypertens"},{"key":"352_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.115.05333","volume":"66","author":"XZ Shen","year":"2015","unstructured":"Shen XZ, Li Y, Li L, Shah KH, Bernstein KE, Lyden P, et al. Microglia participate in neurogenic regulation of hypertension. Hypertension. 2015;66:309\u201316.","journal-title":"Hypertension"},{"key":"352_CR27","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1111\/j.1440-1681.2009.05234.x","volume":"37","author":"P Shi","year":"2010","unstructured":"Shi P, Raizada MK, Sumners C. Brain cytokines as neuromodulators in cardiovascular control. Clin Exp Pharm Physiol. 2010;37:e52\u20137.","journal-title":"Clin Exp Pharm Physiol"},{"key":"352_CR28","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/HYPERTENSIONAHA.116.07747","volume":"68","author":"JE Stern","year":"2016","unstructured":"Stern JE, Son S, Biancardi VC, Zheng H, Sharma N, Patel KP. Astrocytes contribute to angiotensin II stimulation of hypothalamic neuronal activity and sympathetic outflow. Hypertension. 2016;68:1483\u201393.","journal-title":"Hypertension"},{"key":"352_CR29","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1096\/fasebj.31.1_supplement.1010.5","volume":"31","author":"A Setiadi","year":"2017","unstructured":"Setiadi A, May CN, Yao ST. Ablation of astrocytes in the paraventricular nucleus disrupts the blood\u2010brain barrier and increases blood pressure in rats. FASEB J. 2017;31:1010.","journal-title":"FASEB J"},{"key":"352_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/NEN.0b013e31826809a6","volume":"71","author":"Z Michalak","year":"2012","unstructured":"Michalak Z, Lebrun A, Di Miceli M, Rousset MC, Crespel A, Coubes P, et al. IgG leakage may contribute to neuronal dysfunction in drug-refractory epilepsies with blood\u2013brain barrier disruption. J Neuropathol Exp Neurol. 2012;71:826\u201338.","journal-title":"J Neuropathol Exp Neurol"},{"key":"352_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/jnc.13905","volume":"140","author":"A Meissner","year":"2017","unstructured":"Meissner A, Minnerup J, Soria G, Planas AM. Structural and functional brain alterations in a murine model of Angiotensin II-induced hypertension. J Neurochem. 2017;140:509\u201321.","journal-title":"J Neurochem"},{"key":"352_CR32","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/ijms18091965","volume":"18","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki Y, Kanekiyo T. Blood\u2013brain barrier dysfunction and the pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci. 2017;18:1965.","journal-title":"Int J Mol Sci"},{"key":"352_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.07.008","volume":"136","author":"AP Sagare","year":"2012","unstructured":"Sagare AP, Deane R, Zlokovic BV. Low-density lipoprotein receptor-related protein 1: a physiological A\u03b2 homeostatic mechanism with multiple therapeutic opportunities. Pharm Ther. 2012;136:94\u2013105.","journal-title":"Pharm Ther"},{"key":"352_CR34","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41440-018-0090-9","volume":"41","author":"S Foulquier","year":"2018","unstructured":"Foulquier S, Namsolleck P, Van Hagen BT, Milanova I, Post MJ, Blankesteijn WM, et al. Hypertension-induced cognitive impairment: insights from prolonged angiotensin II infusion in mice. Hypertens Res. 2018;41:827.","journal-title":"Hypertens Res"},{"key":"352_CR35","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/jcbfm.2013.143","volume":"33","author":"P Toth","year":"2013","unstructured":"Toth P, Tucsek Z, Sosnowska D, Gautam T, Mitschelen M, Tarantini S, et al. Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. J Cereb Blood Flow Metab. 2013;33:1732\u201342.","journal-title":"J Cereb Blood Flow Metab"},{"key":"352_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0165-0173(00)00043-6","volume":"34","author":"JC de la Torre","year":"2000","unstructured":"de la Torre JC, Stefano GB. Evidence that Alzheimer\u2019s disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Brain Res Rev. 2000;34:119\u201336.","journal-title":"Brain Res Brain Res Rev"},{"key":"352_CR37","first-page":"124","volume":"1","author":"CZ Bueche","year":"2014","unstructured":"Bueche CZ, Hawkes C, Garz C, Vielhaber S, Attems J, Knight RT, et al. Hypertension drives parenchymal \u03b2-amyloid accumulation in the brain parenchyma. Annals of Clinical and Translational. Neurology. 2014;1:124\u20139.","journal-title":"Neurology"},{"key":"352_CR38","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/HYPERTENSIONAHA.113.01063","volume":"62","author":"G Faraco","year":"2013","unstructured":"Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension. 2013;62:810\u20137.","journal-title":"Hypertension"},{"key":"352_CR39","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.neurobiolaging.2008.08.008","volume":"31","author":"LG Apostolova","year":"2010","unstructured":"Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez, et al. Subregional hippocampal atrophy predicts Alzheimer\u2019s dementia in the cognitively normal. Neurobiol Aging. 2010;31:1077\u201388.","journal-title":"Neurobiol Aging"},{"key":"352_CR40","first-page":"205","volume":"6","author":"M Bobinski","year":"1995","unstructured":"Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M, Reisberg B, Mlodzik B, et al. Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia. 1995;6:205\u201310.","journal-title":"Dementia"},{"key":"352_CR41","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1212\/01.WNL.0000158283.28251.3C","volume":"64","author":"JR Jennings","year":"2005","unstructured":"Jennings JR, Muldoon MF, Ryan C, Price JC, Greer P, Sutton-Tyrrell K, et al. Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology. 2005;64:1358\u201365.","journal-title":"Neurology"},{"key":"352_CR42","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1161\/01.STR.27.11.2069","volume":"27","author":"H Tomimoto","year":"1996","unstructured":"Tomimoto H, Akiguchi I, Suenaga T, Nishimura M, Wakita H, Nakamura S, et al. Alterations of the blood\u2013brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer\u2019s disease patients. Stroke. 1996;27:2069\u201374.","journal-title":"Stroke"},{"key":"352_CR43","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00401-016-1570-0","volume":"131","author":"A Montagne","year":"2016","unstructured":"Montagne A, Nation DA, Pa J, Sweeney MD, Toga AW, Zlokovic BV. Brain imaging of neurovascular dysfunction in Alzheimer\u2019s disease. Acta Neuropathol. 2016;131:687\u2013707.","journal-title":"Acta Neuropathol"},{"key":"352_CR44","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1016\/j.lfs.2003.06.014","volume":"73","author":"M Kaya","year":"2003","unstructured":"Kaya M, Kalayci R, K\u00fc\u00e7\u00fck M, Arican N, Elmas I, Kudat H, et al. Effect of losartan on the blood\u2013brain barrier permeability in diabetic hypertensive rats. Life Sci. 2003;73:3235\u201344.","journal-title":"Life Sci"},{"key":"352_CR45","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1126\/science.6879184","volume":"221","author":"D Ganten","year":"1983","unstructured":"Ganten D, Hermann K, Bayer C, Unger T, Lang RE. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science. 1983;221:869\u201371.","journal-title":"Science"},{"key":"352_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrn1902","volume":"7","author":"P Guyenet","year":"2006","unstructured":"Guyenet P. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335\u201346.","journal-title":"Nat Rev Neurosci"},{"key":"352_CR47","doi-asserted-by":"publisher","first-page":"13415","DOI":"10.1073\/pnas.96.23.13415","volume":"96","author":"A Reaux","year":"1999","unstructured":"Reaux A, Fournie-Zaluski MC, David C, Zini S, Roques BP, Corvol P, et al. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci USA. 1999;96:13415\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"352_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1042\/CS20130396","volume":"127","author":"J Gao","year":"2014","unstructured":"Gao J, Marc Y, Iturrioz X, Leroux V, Balavoine F, Llorens-Cortes C. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors. Clin Sci. 2014;127:135\u201348.","journal-title":"Clin Sci"},{"key":"352_CR49","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.amjhyper.2004.09.004","volume":"18","author":"J Tan","year":"2005","unstructured":"Tan J, Wang JM, Leenen FH. Inhibition of brain angiotensin converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats. Am J Hypertens. 2005;18:158\u201364.","journal-title":"Am J Hypertens"},{"key":"352_CR50","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.hjh.0000354511.14086.f1","volume":"27","author":"C Perret\u2010Guillaume","year":"2009","unstructured":"Perret\u2010Guillaume C, Joly L, Jankowski P, Benetos A. Benefits of the RAS blockade: clinical evidence before the ONTARGET study. J Hypertens Suppl. 2009;27:S3\u20137.","journal-title":"J Hypertens Suppl"},{"key":"352_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/HYPERTENSIONAHA.109.138586","volume":"54","author":"S Takeda","year":"2009","unstructured":"Takeda S, Sato N, Takeuchi D, Kurinami H, Shinohara M, Niisato M, et al. Angiotensin receptor blocker prevented \u03b2-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension. 2009;54:6.","journal-title":"Hypertension"},{"key":"352_CR52","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/ajh.2010.241","volume":"24","author":"N Pelisch","year":"2011","unstructured":"Pelisch N, Hosomi N, Ueno M, Nakano D, Hitomi H, Mogi M, et al. Blockade of AT1 receptors protects the blood\u2013brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats. Am J Hypertens. 2011;24:362\u20138.s.","journal-title":"Am J Hypertens"},{"key":"352_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13195-015-0167-5","volume":"28","author":"AG Elkahloun","year":"2016","unstructured":"Elkahloun AG, Hafko R, Saavedra JM. An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer\u2019s disease. Alzheimers Res Ther. 2016;28:5.","journal-title":"Alzheimers Res Ther"},{"key":"352_CR54","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JAD-2011-110347","volume":"26","author":"NM Davies","year":"2011","unstructured":"Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM. Associations of antihypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias. J Alzheimers Dis. 2011;26:699\u2013708.","journal-title":"J Alzheimers Dis"},{"key":"352_CR55","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3233\/JAD-131694","volume":"40","author":"R O\u2019Caoimh","year":"2014","unstructured":"O\u2019Caoimh R, Healy L, Gao Y, Svendrovski A, Kerins DM, Eustace J, et al. Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2014;40:595\u2013603.","journal-title":"J Alzheimers Dis"},{"key":"352_CR56","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","volume":"169","author":"KM Sink","year":"2009","unstructured":"Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, et al. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med. 2009;169:1195\u2013202.","journal-title":"Arch Intern Med"},{"key":"352_CR57","doi-asserted-by":"publisher","first-page":"e002881","DOI":"10.1136\/bmjopen-2013-002881","volume":"3","author":"Y Gao","year":"2013","unstructured":"Gao Y, O\u2019Caoimh R, Healy L, Kerins DM, Eustace J, Guyatt G, et al. Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia. BMJ Open. 2013;3:e002881.","journal-title":"BMJ Open"},{"key":"352_CR58","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","volume":"163","author":"C Tzourio","year":"2003","unstructured":"Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069\u201375.","journal-title":"Arch Intern Med"},{"key":"352_CR59","first-page":"38","volume":"319","author":"S Takakura","year":"1992","unstructured":"Takakura S, Satoh Y, Satoh H, Mori J, Kohsaka M. Effects of nilvadipine on regional cerebral blood flow and skin blood flow in anesthetized cats. Arch Int Pharmacodyn Ther. 1992;319:38\u201348.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"352_CR60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","volume":"10","author":"C Anderson","year":"2011","unstructured":"Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, et al. ONTARGET and TRANSCEND Investigators. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol. 2011;10:43\u201353.","journal-title":"Lancet Neurol"},{"key":"352_CR61","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/gps.1851","volume":"22","author":"H Hanyu","year":"2007","unstructured":"Hanyu H, Hirao K, Shimizu S, Sato T, Kiuchi A, Iwamoto T. Nilvadipine prevents cognitive decline of patients with mild cognitive impairment. Int J Geriatr Psychiatry. 2007;22:1264\u20136.","journal-title":"Int J Geriatr Psychiatry"},{"key":"352_CR62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jns.2009.02.335","volume":"283","author":"F Amenta","year":"2009","unstructured":"Amenta F, Lanari A, Mignini F, Silvestrelli G, Traini E, Tomassoni D. Nicardipine use in cerebrovascular disease: a review of controlled clinical studies. J Neurological Sci. 2009;283:219\u201323.","journal-title":"J Neurological Sci"},{"key":"352_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainres.2003.11.061","volume":"999","author":"D Paris","year":"2004","unstructured":"Paris D, Quadros A, Humphrey J, Patel N, Crescentini R, Crawford F, et al. Nilvadipine antagonizes both A beta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPSW transgenic mice. Brain Res. 2004;999:53\u201361.","journal-title":"Brain Res"},{"key":"352_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1476-5381.1983.tb10506.x","volume":"79","author":"L Edvinsson","year":"1983","unstructured":"Edvinsson L, Johansson BB, Larsson B, MacKenzie ET, Sk\u00e4rby T, Young AR. Calcium antagonists: effects on cerebral blood flow and blood\u2013brain barrier permeability in the rat. Br J Pharm. 1983;79:141\u20138.","journal-title":"Br J Pharm"},{"key":"352_CR65","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/00207450490422821","volume":"114","author":"A Nukhet Turkel","year":"2004","unstructured":"Nukhet Turkel A, Ziya Ziylan Y. Protection of blood\u2013brain barrier breakdown by nifedipine in adrenaline-induced acute hypertension. Int J Neurosci. 2004;114:517\u201328.","journal-title":"Int J Neurosci"},{"key":"352_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fnins.2019.00033","volume":"13","author":"C Laurens","year":"2019","unstructured":"Laurens C, Abot A, Delarue A, Knauf C. Central effects of beta-blockers may be due to nitric oxide and hydrogen peroxide release independently of their ability to cross the blood\u2013brain barrier. Front Neurosci. 2019;13:33.","journal-title":"Front Neurosci"},{"key":"352_CR67","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1212\/WNL.0b013e3182a351d4","volume":"81","author":"RP Gelber","year":"2013","unstructured":"Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, White LR. Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study. Neurology. 2013;81:888\u201395.","journal-title":"Neurology"},{"key":"352_CR68","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","volume":"63","author":"AS Khachaturian","year":"2006","unstructured":"Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006;63:686\u201392.","journal-title":"Arch Neurol"},{"key":"352_CR69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.brainres.2005.05.064","volume":"1051","author":"G Lenzs\u00e9r","year":"2005","unstructured":"Lenzs\u00e9r G, Kis B, Bari F, Busija DW. Diazoxide preconditioning attenuates global cerebral ischemia-induced BBB permeability. Brain Res. 2005;1051:72\u201380.","journal-title":"Brain Res"},{"key":"352_CR70","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1254\/jphs.SC0060222","volume":"103","author":"T Nishioku","year":"2007","unstructured":"Nishioku T, Takata F, Yamauchi A, Sumi N, Yamamoto I, Fujino A, et al. Protective action of indapamide, a thiazide-like diuretic, on ischemia-induced injury and barrier dysfunction in mouse brain microvascular endothelial cells. J Pharm Sci. 2007;103:323\u20137.","journal-title":"J Pharm Sci"},{"key":"352_CR71","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3389\/fphys.2017.01048","volume":"8","author":"L Buttler","year":"2017","unstructured":"Buttler L, Jord\u00e3o MT, Fragas MG, Ruggeri A, Ceroni A, Michelini LC. Maintenance of blood\u2013brain barrier integrity in hypertension: a novel benefit of exercise training for autonomic control. Front Physiol. 2017;8:1048.","journal-title":"Front Physiol"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41371-020-0352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-020-0352-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-020-0352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T23:21:13Z","timestamp":1722900073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-020-0352-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1038\/s41371-020-0352-2","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"24 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}